ArticleGastroenterology & hepatology2016
Vaccinating Patients With Inflammatory Bowel Disease.
Article in Gastroenterology & hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- A guide to healthcare maintenance for the patient with inflammatory bowel disease.Annals of gastroenterology · 2026Review
- Article
- Prevalence of opportunistic infections in Syrian inflammatory bowel disease patients on biologic therapy: a multi-center retrospective cross-sectional study.BMC infectious diseases · 2025Article
- Ameliorative Effect of Banana Lectin in TNBS-Induced Colitis in C57BL/6 Mice Relies on the Promotion of Antioxidative Mechanisms in the Colon.Biomolecules · 2025Article
- Vaccine Knowledge and Awareness Among Patients With Chronic Inflammatory Diseases: Results From a Nordic Survey.Journal of patient experience · 2025Article
- Pulmonary Manifestations of IBD: Case Report and Review of the Literature.Journal of clinical medicine · 2024Review
- Banana Lectin: A Novel Immunomodulatory Strategy for Mitigating Inflammatory Bowel Disease.Nutrients · 2024Article
- Immunization of children with inflammatory bowel disease against SARS-CoV-19 infection: A prospective single centre cohort study.Vaccine: X · 2023Article
- Prevalence Rates of Pneumococcal Vaccination in IBD and 30-Day Clinical Outcomes in Patients With IBD and Pneumococcal Disease Stratified by Receipt of Pneumococcal Vaccination: A Multi-Network Study.Crohn's & colitis 360 · 2023Article
- Vaccination in patients with inflammatory bowel disease-Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn's and Colitis meeting.Intestinal research · 2023Article
- Unilateral Episcleritis Following COVID-19 Booster Vaccination of a Crohn's Disease Patient: A Case Report and Review of the Literature.International medical case reports journal · 2023Article
- Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases.The Korean journal of internal medicine · 2022Article
- Personalised medicine in IBD: don't dispose of the sledgehammer just yet.Therapeutic advances in gastroenterology · 2022Article
- Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study.PloS one · 2022Article
- Health Maintenance for Adult Patients with Inflammatory Bowel Disease.Current treatment options in gastroenterology · 2021Review
- The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.Inflammatory bowel diseases · 2020Article
- The role of the dermatologist in the return of measles.International journal of women's dermatology · 2020Article
- Article
- Personalising medicine in inflammatory bowel disease-current and future perspectives.Translational pediatrics · 2019Review
- Health Maintenance and Vaccination of Patients With Inflammatory Bowel Disease: Practice and Perception of Responsibility of Gastroenterologists vs Primary Care Providers.Ochsner journal · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with inflammatory bowel disease (IBD) are not vaccinated at the same rate as general medical patients. IBD places patients at increased risk for developing vaccine-preventable illnesses, and this risk is further exacerbated by immunosuppressive therapy. Therefore, gastroenterologists should familiarize themselves with health maintenance measures pertaining to patients with IBD. This article highlights the vaccinations required for patients with IBD, especially those who are immunosuppressed: influenza; pneumococcal pneumonia; hepatitis A and B viruses; human papilloma virus; meningococcal disease; tetanus, diphtheria, and pertussis; measles, mumps, and rubella; varicella zoster; and herpes zoster. This article also discusses issues regarding patients with IBD who travel outside of the United States, as well as highlights and provides suggestions for areas of quality improvement that are needed in the field.
Indexed as
Identifiers
27917091PMC5114511What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.